CN4- ECONOMIC EVALUATION OF GEMZAR/CISPLATIN RELATIVE TO OTHER CISPLATIN BASED TREATMENTS FOR NON SMALL CELL LUNG (NSCLC) CANCER IN THE UK
Abstract
Authors
N Botwood J McKendrick M Aristides M Lees N Maniadakis W Wein D Stephenson